MEDP
Medpace Holdings, Inc. NASDAQ Listed Aug 11, 2016$624.20
+1.94%
vs $612.33
Mkt Cap $18.4B
52w Low $393.42
100.0% of range
52w High $624.20
50d MA $586.50
200d MA $521.11
P/E (TTM)
36.6x
EV/EBITDA
30.0x
P/B
39.2x
Debt/Equity
0.6x
ROE
77.0%
P/FCF
27.0x
RSI (14)
67.10
ATR (14)
$13.16
Beta
1.39
50d MA
$586.50
200d MA
$521.11
Avg Volume
213.5K
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
5375 Medpace Way · Cincinnati, OH 45227 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | AMC | 3.98 | 4.25 | +6.8% | 528.12 | +22.5% | +14.7% | -0.7% | -2.0% | -3.1% | +2.4% | — |
| Apr 22, 2026 | AMC | 3.92 | 4.28 | +9.2% | 508.46 | -26.2% | -22.6% | +4.4% | +2.6% | -2.8% | +1.0% | — |
| Feb 9, 2026 | AMC | 4.19 | 4.67 | +11.5% | 530.35 | -7.8% | -15.9% | -5.0% | -1.9% | +2.9% | +0.0% | — |
| Oct 22, 2025 | AMC | 3.53 | 3.86 | +9.3% | 546.74 | +13.3% | +9.1% | +1.4% | -1.4% | -2.7% | +0.7% | — |
| Jul 21, 2025 | AMC | 2.98 | 3.10 | +4.0% | 308.88 | +44.3% | +54.7% | -8.4% | +4.2% | -1.8% | +1.2% | — |
| Apr 21, 2025 | AMC | 3.06 | 3.67 | +19.9% | 288.99 | -10.3% | -2.3% | +2.9% | +4.2% | -1.4% | -0.1% | — |
| Feb 10, 2025 | AMC | 2.96 | 3.67 | +24.0% | 354.51 | -3.9% | -7.5% | +2.6% | +1.8% | -0.7% | +0.2% | — |
| Oct 21, 2024 | AMC | 2.78 | 3.01 | +8.3% | 352.92 | -13.6% | -7.5% | +1.1% | -0.6% | +0.7% | -0.3% | — |
| Jul 22, 2024 | AMC | 2.54 | 2.75 | +8.3% | 437.18 | -17.5% | -18.3% | +6.9% | -0.4% | +0.3% | +1.0% | — |
| Apr 22, 2024 | AMC | 2.47 | 3.20 | +29.6% | 376.26 | +0.5% | +8.2% | -2.4% | -2.0% | +1.6% | +1.1% | — |
| Feb 12, 2024 | AMC | 2.22 | 2.46 | +10.8% | 324.21 | +0.8% | +12.3% | +7.1% | +1.2% | -0.7% | -1.9% | — |
| Oct 23, 2023 | AMC | 2.05 | 2.22 | +8.3% | 227.52 | +9.9% | +19.7% | -5.1% | -1.0% | -2.2% | -3.4% | — |
| Jul 24, 2023 | AMC | 1.91 | 1.93 | +1.0% | 246.94 | -6.9% | +3.9% | -0.0% | -3.0% | +2.4% | -0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 8 | Robert W. Baird | Downgrade | Outperform → Neutral | $547 | $546.29 | $534.82 | -2.1% | -2.6% | +0.7% | +0.5% | -1.5% | +1.1% |
| Jul 7 | Jefferies | Downgrade | Buy → Hold | $515 | $565.09 | $556.47 | -1.5% | -3.3% | -2.6% | +0.7% | +0.5% | -1.5% |
| Apr 24 | RBC Capital | Maintains | Outperform → Outperform | — | $393.42 | $390.01 | -0.9% | +4.4% | +2.6% | -2.8% | +1.0% | +1.2% |
| Apr 24 | BMO Capital | Maintains | Market Perform → Market Perform | — | $393.42 | $390.01 | -0.9% | +4.4% | +2.6% | -2.8% | +1.0% | +1.2% |
| Apr 24 | Barclays | Maintains | Equal Weight → Equal Weight | — | $393.42 | $390.01 | -0.9% | +4.4% | +2.6% | -2.8% | +1.0% | +1.2% |
| Apr 24 | Baird | Maintains | Outperform → Outperform | — | $393.42 | $390.01 | -0.9% | +4.4% | +2.6% | -2.8% | +1.0% | +1.2% |
| Mar 6 | Barclays | Upgrade | Underweight → Equal Weight | — | $469.38 | $469.50 | +0.0% | +0.3% | +1.7% | -2.5% | +2.3% | -7.1% |
| Feb 18 | TD Cowen | Upgrade | Sell → Hold | — | $428.18 | $432.16 | +0.9% | +4.2% | +0.1% | +1.6% | -1.9% | -0.6% |
| Feb 13 | Jefferies | Upgrade | Hold → Buy | — | $416.04 | $421.45 | +1.3% | +2.9% | +0.0% | +4.2% | +0.1% | +1.6% |
| Feb 11 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $446.05 | $446.83 | +0.2% | -5.0% | -1.9% | +2.9% | +0.0% | +4.2% |
| Feb 11 | Barclays | Maintains | Underweight → Underweight | — | $446.05 | $446.83 | +0.2% | -5.0% | -1.9% | +2.9% | +0.0% | +4.2% |
| Feb 11 | Truist | Maintains | Hold → Hold | — | $446.05 | $446.83 | +0.2% | -5.0% | -1.9% | +2.9% | +0.0% | +4.2% |
| Dec 15 | Barclays | Maintains | Underweight → Underweight | — | $557.90 | $557.90 | +0.0% | +0.2% | -0.1% | -0.3% | +0.6% | +1.5% |
| Oct 27 | Truist | Maintains | Hold → Hold | — | $605.20 | $606.59 | +0.2% | -1.4% | -2.7% | +0.7% | -0.7% | +0.8% |
| Oct 24 | Mizuho | Maintains | Outperform → Outperform | — | $596.61 | $603.05 | +1.1% | +1.4% | -1.4% | -2.7% | +0.7% | -0.7% |
| Oct 24 | Barclays | Maintains | Underweight → Underweight | — | $596.61 | $603.05 | +1.1% | +1.4% | -1.4% | -2.7% | +0.7% | -0.7% |
| Oct 24 | TD Cowen | Maintains | Sell → Sell | — | $596.61 | $603.05 | +1.1% | +1.4% | -1.4% | -2.7% | +0.7% | -0.7% |
| Oct 17 | Mizuho | Maintains | Outperform → Outperform | — | $521.21 | $520.49 | -0.1% | +1.3% | +3.1% | +0.2% | +0.2% | +9.1% |
| Oct 2 | Barclays | Downgrade | Equal Weight → Underweight | — | $543.90 | $525.75 | -3.3% | -1.4% | -0.7% | -0.4% | +0.3% | -0.2% |
| Sep 9 | Jefferies | Maintains | Hold → Hold | — | $492.09 | $491.37 | -0.1% | -1.3% | -1.8% | +4.4% | -1.4% | +1.2% |
| Sep 3 | Rothschild & Co | Downgrade | Buy → Neutral | — | $473.34 | $468.09 | -1.1% | +1.7% | +0.2% | +1.0% | +1.0% | -1.3% |
| Jul 29 | UBS | Downgrade | Neutral → Sell | — | $453.05 | $431.89 | -4.7% | -1.1% | -2.3% | -2.4% | -1.0% | +2.2% |
| Jul 25 | Mizuho | Maintains | Outperform → Outperform | — | $455.68 | $445.00 | -2.3% | -1.8% | +1.2% | -1.1% | -2.3% | -2.4% |
| Jul 23 | Truist | Maintains | Hold → Hold | — | $477.73 | $470.70 | -1.5% | -8.4% | +4.2% | -1.8% | +1.2% | -1.1% |
| Jul 23 | Deutsche Bank | Maintains | Hold → Hold | — | $477.73 | $470.70 | -1.5% | -8.4% | +4.2% | -1.8% | +1.2% | -1.1% |
| Jul 23 | TD Cowen | Downgrade | Hold → Sell | — | $477.73 | $470.70 | -1.5% | -8.4% | +4.2% | -1.8% | +1.2% | -1.1% |
| Jul 23 | Barclays | Maintains | Equal Weight → Equal Weight | — | $477.73 | $470.70 | -1.5% | -8.4% | +4.2% | -1.8% | +1.2% | -1.1% |
| Jul 23 | Baird | Maintains | Neutral → Neutral | — | $477.73 | $470.70 | -1.5% | -8.4% | +4.2% | -1.8% | +1.2% | -1.1% |
| Apr 23 | Truist | Maintains | Hold → Hold | — | $282.28 | $293.42 | +3.9% | +2.9% | +4.2% | -1.4% | -0.1% | +2.7% |
| Apr 23 | Baird | Maintains | Neutral → Neutral | — | $282.28 | $293.42 | +3.9% | +2.9% | +4.2% | -1.4% | -0.1% | +2.7% |
| Apr 22 | William Blair | Downgrade | Outperform → Market Perform | — | $288.99 | $259.13 | -10.3% | -2.3% | +2.9% | +4.2% | -1.4% | -0.1% |
| Apr 14 | TD Cowen | Downgrade | Buy → Hold | — | $297.72 | $298.42 | +0.2% | +2.5% | -0.1% | -2.8% | -0.1% | -2.5% |
| Apr 10 | Truist | Maintains | Hold → Hold | — | $302.56 | $297.85 | -1.6% | -6.7% | +5.5% | +2.5% | -0.1% | -2.8% |
| Apr 9 | Mizuho | Maintains | Outperform → Outperform | — | $277.23 | $274.58 | -1.0% | +9.1% | -6.7% | +5.5% | +2.5% | -0.1% |
| Jan 27 | Baird | Maintains | Neutral → Neutral | — | $344.07 | $343.47 | -0.2% | +1.8% | -1.3% | -0.8% | +2.0% | -0.3% |
| Nov 25 | Baird | Maintains | Neutral → Neutral | — | $337.75 | $341.65 | +1.2% | +0.0% | -0.8% | +1.1% | +0.5% | +0.5% |
| Oct 23 | TD Cowen | Maintains | Buy → Buy | — | $326.54 | $326.49 | -0.0% | +1.1% | -0.6% | +0.7% | -0.3% | +0.1% |
| Oct 23 | Baird | Downgrade | Outperform → Neutral | — | $326.54 | $326.49 | -0.0% | +1.1% | -0.6% | +0.7% | -0.3% | +0.1% |
| Oct 14 | Truist | Maintains | Hold → Hold | — | $347.91 | $350.00 | +0.6% | +1.6% | -0.1% | -1.9% | -1.0% | +3.9% |
| Sep 27 | UBS | Downgrade | Buy → Neutral | — | $326.26 | $322.09 | -1.3% | +1.6% | +0.7% | -0.1% | +1.0% | +0.3% |
| Sep 25 | Jefferies | Downgrade | Buy → Hold | — | $355.82 | $346.07 | -2.7% | -9.9% | +1.8% | +1.6% | +0.7% | -0.1% |
| Sep 20 | Baird | Maintains | Outperform → Outperform | — | $369.18 | $367.98 | -0.3% | -0.9% | -1.0% | -1.7% | -9.9% | +1.8% |
| Jul 24 | Guggenheim | Maintains | Buy → Buy | — | $357.30 | $357.30 | +0.0% | +6.9% | -0.4% | +0.3% | +1.0% | -1.8% |
| Jul 24 | Deutsche Bank | Maintains | Hold → Hold | — | $357.30 | $357.30 | +0.0% | +6.9% | -0.4% | +0.3% | +1.0% | -1.8% |
| Jul 24 | TD Cowen | Maintains | Buy → Buy | — | $357.30 | $357.30 | +0.0% | +6.9% | -0.4% | +0.3% | +1.0% | -1.8% |
| Jul 24 | Baird | Maintains | Outperform → Outperform | — | $357.30 | $357.30 | +0.0% | +6.9% | -0.4% | +0.3% | +1.0% | -1.8% |
| Jul 8 | Baird | Maintains | Outperform → Outperform | — | $402.40 | $404.75 | +0.6% | +0.8% | +1.3% | +2.0% | +3.8% | +1.8% |
| Apr 24 | Guggenheim | Maintains | Buy → Buy | — | $407.15 | $415.00 | +1.9% | -2.4% | -2.0% | +1.6% | +1.1% | -3.0% |
| Apr 24 | Baird | Maintains | Outperform → Outperform | — | $407.15 | $415.00 | +1.9% | -2.4% | -2.0% | +1.6% | +1.1% | -3.0% |
| Apr 23 | Jefferies | Upgrade | Hold → Buy | — | $376.26 | $378.00 | +0.5% | +8.2% | -2.4% | -2.0% | +1.6% | +1.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Troendle August J.Dir/Off | President & CEO | Sell | 10,880 | $620.40 | $6.7M | 504,273 | — | — |
| Sep 16, 2026 | Troendle August J.Dir/Off | President & CEO | Sell | 8,770 | $621.29 | $5.4M | 515,153 | -0.46% | — |
| Sep 15, 2026 | Troendle August J.Dir/Off | President & CEO | Sell | 15,971 | $620.84 | $9.9M | 523,923 | -0.46% | — |
| Aug 27, 2026 | Troendle August J.Dir/Off | President & CEO | Sell | 650 | $620.27 | $403K | 539,894 | -1.81% | -0.07% |
| Aug 26, 2026 | Troendle August J.Dir/Off | President & CEO | Sell | 4,000 | $620.03 | $2.5M | 540,544 | -1.79% | +0.06% |
| Aug 25, 2026 | Troendle August J.Dir/Off | President & CEO | Sell | 673 | $620.38 | $418K | 544,544 | -1.79% | +0.06% |
| Aug 24, 2026 | Troendle August J. | President & CEO | Sell | 1,983 | $620.23 | $1.2M | 545,217 | +0.81% | -1.81% |
| Aug 21, 2026 | Troendle August J. | President & CEO | Sell | 13,995 | $624.45 | $8.7M | 547,200 | +0.81% | -1.81% |
| Aug 20, 2026 | Brady Kevin M. | CFO & Treasurer | Sell | 3,400 | $625.24 | $2.1M | 12,830 | -0.96% | -1.11% |
| Aug 20, 2026 | Troendle August J. | President & CEO | Sell | 27,174 | $618.79 | $16.8M | 561,195 | -0.12% | -1.79% |
| Aug 19, 2026 | DAVENPORT FRED B JR | — | Sell | 7,283 | $606.15 | $4.4M | 3,798 | -0.12% | -1.79% |
| Aug 19, 2026 | Carley Brian T | — | Sell | 5,000 | $608.63 | $3.0M | 27,825 | -0.12% | -1.79% |
| Aug 19, 2026 | Troendle August J. | President & CEO | Sell | 15,609 | $606.47 | $9.5M | 588,369 | -0.12% | -1.79% |
| Aug 13, 2026 | Troendle August J. | President & CEO | Sell | 458 | $600.39 | $275K | 603,978 | +3.22% | +1.32% |
| Aug 12, 2026 | Troendle August J. | President & CEO | Sell | 11,366 | $601.53 | $6.8M | 604,436 | +3.22% | +1.32% |
| Aug 11, 2026 | McCarthy Cornelius P. IIIDir | — | Sell | 1,140 | $605.37 | $690K | 12,275 | -0.59% | +0.72% |
| Aug 11, 2026 | Troendle August J.Dir/Off | President & CEO | Sell | 17,610 | $605.11 | $10.7M | 615,802 | -2.52% | +3.04% |
| Aug 10, 2026 | Troendle August J.Dir/Off | President & CEO | Sell | 5,534 | $601.53 | $3.3M | 633,412 | -2.52% | +3.04% |
| Aug 7, 2026 | McCarthy Cornelius P. IIIDir | — | Sell | 795 | $585.07 | $465K | 13,415 | -1.41% | -1.14% |
| Jul 28, 2026 | Troendle August J.Dir/Off | President & CEO | Sell | 3,510 | $600.01 | $2.1M | 638,946 | -1.13% | +2.20% |
| Jul 28, 2026 | BURWIG SUSAN EOff | Exec. VP, Operations | Sell | 7,500 | $600.00 | $4.5M | 62,984 | -1.13% | +2.20% |
| Jul 27, 2026 | Troendle August J.Dir/Off | President & CEO | Sell | 3,728 | $600.85 | $2.2M | 642,456 | -1.13% | +2.20% |
| May 28, 2026 | EWALD STEPHEN POff | General Counsel & Corp. Secy. | Sell | 16,349 | $450.00 | $7.4M | 20,343 | -1.30% | +0.80% |
8-K · 2.02
!! High
Medpace Holdings, Inc. -- 8-K 2.02: Earnings Results
Medpace Holdings reported earnings results showing its operational performance and financial condition, with full details available in the accompanying press release for investor review.
Jul 22
8-K
Medpace Holdings, Inc. -- 8-K Filing
May 19
8-K · 5.02
!!! Very High
Medpace Holdings, Inc. -- 8-K 5.02: Executive Change
Jesse Geiger's resignation as President of Medpace Holdings, effective May 31, 2026, signals upcoming leadership transition that investors should monitor for potential operational strategy changes and successor announcement.
Apr 22
8-K
Medpace Holdings, Inc. -- 8-K Filing
Medpace Holdings achieved strong 32% revenue growth in Q4 2025 to $708.5 million, demonstrating robust business momentum and effective backlog conversion at a 23.6% rate.
Feb 9
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 2,498,248 | $1.3B | New | Jun 2026 |
| 2 | Aqr Capital Management Llc | 1,278,935 | $677M | Reduced | Jun 2026 |
| 3 | Vanguard Portfolio Management Llc | 1,133,357 | $600M | Added | Jun 2026 |
| 4 | Vanguard Capital Management Llc | 1,026,820 | $544M | Added | Jun 2026 |
| 5 | Morgan Stanley | 833,356 | $468M | Reduced | Dec 2025 |
| 6 | Wasatch Advisors Lp | 636,595 | $337M | Reduced | Jun 2026 |
| 7 | Invesco Ltd. | 577,574 | $277M | Added | Mar 2026 |
| 8 | Renaissance Technologies Llc | 415,588 | $220M | Reduced | Jun 2026 |
| 9 | Arrowstreet Capital, Limited Partnership | 395,769 | $190M | Added | Mar 2026 |
| 10 | Ubs Group Ag | 340,433 | $163M | Added | Mar 2026 |
| 11 | Td Asset Management Inc | 263,872 | $140M | New | Jun 2026 |
| 12 | Turtle Creek Asset Management Inc. | 271,140 | $130M | Added | Mar 2026 |
| 13 | Madison Asset Management, Llc | 243,502 | $129M | Reduced | Jun 2026 |
| 14 | D. E. Shaw & Co., Inc. | 234,537 | $124M | Reduced | Jun 2026 |
| 15 | Norges Bank | 226,954 | $120M | New | Jun 2026 |
| 16 | Northern Trust Corp | 226,280 | $109M | Added | Mar 2026 |
| 17 | Bank Of America Corp /de/ | 212,183 | $102M | Reduced | Mar 2026 |
| 18 | Riverbridge Partners Llc | 183,941 | $97M | Reduced | Jun 2026 |
| 19 | Franklin Resources Inc | 201,711 | $97M | Reduced | Mar 2026 |
| 20 | Clearbridge Investments, Llc | 175,966 | $84M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$18.43B
Enterprise Value
$18.05B
P/E (TTM)
36.57x
Forward P/E
36.75x
PEG Ratio
1.82x
P/B
39.22x
P/S
6.62x
P/FCF
27.03x
EV/EBITDA
29.97x
Shares Out
29.5M
Financials (TTM)
Revenue
$2.78B
Net Income
$491.5M
EBITDA
$602.2M
Free Cash Flow
$681.9M
Op Cash Flow
$713.2M
EPS Basic
$15.64
EPS Diluted
$17.07
EPS Forward
$16.99
Gross Margin
28.8%
Op Margin
21.0%
Net Margin
17.7%
Balance Sheet
Total Assets
$1.98B
Total Liab.
$1.52B
Total Equity
$459.1M
Cash
$497.0M
LT Debt
$113.6M
Book Value/Sh
$15.91
Debt/Equity
0.55x
Current Ratio
0.74
Quick Ratio
0.74
Returns & Growth
ROE
77.0%
ROA
21.6%
ROIC
67.9%
Rev Growth YoY
+20.0%
EPS Growth YoY
+19.8%
Price Returns
2W
+3.2%
1M
+0.7%
3M
+34.4%
6M
+32.8%
12M
+22.8%
Technicals
52W High
$624.20
52W Low
$393.42
50d MA
$586.50
200d MA
$521.11
RSI (14)
67.10
ATR (14)
$13.16
Beta
1.39
Avg Volume
213K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$498.86
High
$582.00
Low
$400.00
Median
$484.00
Data updated apr 26, 2026 11:47am
· Source: financialmodelingprep.com